Cipher Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	50.94	50.45	33.36	21.16	20.68	21.94
Revenue Growth (YoY)	28.90%	51.22%	57.66%	2.36%	-5.78%	1.55%
Cost of Revenue	9.36	10.03	9.26	4.07	3.99	3.68
Gross Profit	41.58	40.42	24.1	17.09	16.68	18.26
Selling, General & Admin	14.6	16.66	14.95	5.69	4.55	5.11
Depreciation & Amortization Expenses	7.22	7.23	4.02	1.23	0.99	-
Research & Development	-	0.02	-	0.14	0.1	0.09
Other Operating Expenses	-0.06	-	-	-	-	1.25
Total Operating Expenses	21.76	23.91	18.97	7.06	5.63	6.45
Operating Income	19.82	16.51	5.13	10.03	11.05	11.81
Interest Income	-	-	0.33	1.87	0.46	-
Other Non-Operating Income (Expense)	0.41	0.52	-2.51	0.78	-0.04	-0.75
Total Non-Operating Income (Expense)	0.41	0.52	-2.18	2.65	0.43	-0.75
Pretax Income	20.23	17.03	2.96	12.68	11.48	11.06
Provision for Income Taxes	-10.64	-10.17	-8.59	-7.7	-15.16	3.3
Net Income	30.87	27.2	11.55	20.38	26.64	7.76
Net Income to Common	30.87	27.2	11.55	20.38	26.64	7.76
Net Income Growth	215.30%	135.59%	-43.36%	-23.48%	243.34%	76.88%
Shares Outstanding (Basic)	25	25	25	25	27	27
Shares Outstanding (Diluted)	26	26	25	25	27	27
Shares Change (YoY)	-4.10%	2.70%	-0.79%	-5.25%	-	-1.96%
EPS (Basic)	1.21	1.07	0.47	0.82	1.05	0.29
EPS (Diluted)	1.18	1.05	0.46	0.80	1.03	0.29
EPS Growth	227.78%	128.26%	-42.50%	-22.33%	255.17%	81.25%
Shares Outstanding	25.28	25.37	25.6	23.99	25.06	25.94
Free Cash Flow	-	0	19.5	15.98	10.64	13.81
Free Cash Flow Growth	-	-	22.05%	50.11%	-22.95%	18.26%
Free Cash Flow Per Share	-	-	0.77	0.63	0.40	0.51
Gross Margin	81.63%	80.12%	72.24%	80.77%	80.69%	83.21%
Operating Margin	38.91%	32.73%	15.39%	47.41%	53.45%	53.82%
Profit Margin	60.60%	53.91%	34.60%	96.32%	128.83%	35.36%
FCF Margin	-	0.00%	58.45%	75.50%	51.48%	62.95%
EBITDA	19.82	16.51	9.15	11.26	12.04	12.51
EBITDA Margin	38.91%	32.73%	27.43%	53.21%	58.23%	57.01%
EBIT	19.82	16.51	5.13	10.03	11.05	11.81
EBIT Margin	38.91%	32.73%	15.39%	47.41%	53.45%	53.82%
Effective Tax Rate	-52.62%	-59.68%	-290.69%	-60.74%	-132.04%	29.85%

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.